Jump to navigation Jump to search
Armstrong PW, et al. "Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction". NEJM. 2013. 368(15):1379-87.
As of June 2018, no guidelines have been published that reflect the results of this trial.
- Multicenter, open-label, parallel-group, randomized, controlled trial
- Intervention (n=)
- Placebo (n=)
- Mean follow-up:
- Primary Outcome: 30-day composite of death from any cause, shock, congestive heart failure, or reinfarction
BLANK Group displayed
- Physiologic parameters:
- Anthropomorphics: Weight
- Site of infection
Comparisons are BLANK therapy vs. BLANK therapy.